Free Trial

Geron (GERN) News Today

Geron logo
$1.30 -0.03 (-1.89%)
As of 10:10 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Geron Co. stock logo
Russell Investments Group Ltd. Lowers Stake in Geron Co. (NASDAQ:GERN)
Russell Investments Group Ltd. lessened its holdings in Geron Co. (NASDAQ:GERN - Free Report) by 8.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,267,808 shares of the biopharmaceutical company's stock after selling 221,453 shares
Geron (GERN) to Announce Q1 Financial Results
Geron Co. stock logo
Geron (NASDAQ:GERN) Sets New 52-Week Low - Should You Sell?
Geron (NASDAQ:GERN) Hits New 12-Month Low - Should You Sell?
Geron Co. stock logo
Vanguard Group Inc. Raises Position in Geron Co. (NASDAQ:GERN)
Vanguard Group Inc. grew its position in shares of Geron Co. (NASDAQ:GERN - Free Report) by 3.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 33,538,822 shares of the biopharmaceutical company's stock
Should You Invest in Geron Corporation (GERN)?
Should You Invest in Geron Corporation (GERN)?
Geron Co. stock logo
ADAR1 Capital Management LLC Reduces Holdings in Geron Co. (NASDAQ:GERN)
ADAR1 Capital Management LLC reduced its position in Geron Co. (NASDAQ:GERN - Free Report) by 39.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 337,676 shares of the biopharmaceutical company's stock after selling 219,483 shares during the period.
Geron Co. stock logo
Wellington Management Group LLP Has $47.83 Million Stock Holdings in Geron Co. (NASDAQ:GERN)
Wellington Management Group LLP raised its position in shares of Geron Co. (NASDAQ:GERN - Free Report) by 6.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,510,114 shares of th
Geron Co. stock logo
Geron Co. (NASDAQ:GERN) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Geron Co. (NASDAQ:GERN - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eleven research firms that are presently covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation, seven have
Remove Ads
Get Geron News Delivered to You Automatically

Sign up to receive the latest news and ratings for GERN and its competitors with MarketBeat's FREE daily newsletter.

GERN Media Mentions By Week

GERN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GERN
News Sentiment

0.04

0.80

Average
Medical
News Sentiment

GERN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GERN Articles
This Week

36

9

GERN Articles
Average Week

Remove Ads
Get Geron News Delivered to You Automatically

Sign up to receive the latest news and ratings for GERN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:GERN) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners